A possible explanation for the racial difference in distribution of large-arterial cerebrovascular disease: Ancestral European settlers evolved genetic resistance to atherosclerosis, but confined to the intracranial arteries-Reference-Cited by-同舟云学术

A possible explanation for the racial difference in distribution of large-arterial cerebrovascular disease: Ancestral European settlers evolved genetic resistance to atherosclerosis, but confined to the intracranial arteries

Published:2005-01 Issue:4 Volume:65 Page:637-648
ISSN:0306-9877
Container-title:Medical Hypotheses
language:en
Short-container-title:Medical Hypotheses

Author:

Mak W.,Cheng T.S.,Chan K.H.,Cheung R.T.F.,Ho S.L.

Publisher

Elsevier BV

Subject

General Medicine

Reference144 articles.

1. Race, sex and occlusive cerebrovascular disease. A review;Caplan;Stroke,1986

2. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial;Adams;Stroke,1993

3. The Harvard Cooperative Stroke Registry: a prospective registry;Mohr;Neurology,1978

4. Stroke in the Lehigh Valley: racial/ethnic differences;Friday;Neurology,1989

5. Subtypes of ischemic stroke. A hospital-based stroke registry in Taiwan (SCAN-IV);Yip;Stroke,1997

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetics of Carotid Atherosclerosis;Stroke Genetics;2024

2. The association of intracranial atherosclerosis with cerebral small vessel disease imaging markers: a high-resolution magnetic resonance imaging study;Scientific Reports;2023-10-09

3. Prevalence and Characteristics of Symptomatic Intracranial Atherosclerotic Plaques in People Residing at Middle and High Altitudes: A Preliminary Study;Discovery Medicine;2023

4. Association between carotid atherosclerosis and presence of intracranial atherosclerosis using three-dimensional high-resolution vessel wall magnetic resonance imaging in asymptomatic patients with type 2 diabetes;Diabetes Research and Clinical Practice;2022-09

5. New Horizons in Pharmacologic Therapy for Secondary Stroke Prevention;JAMA Neurology;2020-10-01